"Picture this"- Patients' Drawings of Non-Muscle Invasive Bladder Cancer: A Novel Method to Help Understand How Patients Perceive Their Condition [0.03%]
“想象一下”——膀胱非肌层浸润性膀胱癌患者的绘画：一种帮助了解患者如何感知自身病情的新方法
Helen L Richards,Paul Sweeney,Rebekah Corscadden et al.
Helen L Richards et al.
Background: There is a paucity of data regarding patient experiences of living with non-muscle-invasive bladder cancer (NMIBC). Objectives: ...
Systematic Review of the Role of BCG in the Treatment of Urothelial Carcinoma of the Prostatic Urethra [0.03%]
BCG在前列腺尿道尿路上皮癌治疗中作用的系统评价
Oliver Patschan,Philippe E Spiess,George N Thalmann et al.
Oliver Patschan et al.
Background: In patients with non-invasive urothelial carcinoma of the prostatic urethra (PUC), treatment with Bacillus Calmette-Guérin (BCG) could be beneficial. ...
Mark S Soloway,Neil A Abrahams
Mark S Soloway
Implications for Efficacy and Safety of Total Dose and Dose-Intensity of Neoadjuvant Gemcitabine-Cisplatin in Muscle-Invasive Bladder Cancer: Three-Week Versus Four-Week Regimen [0.03%]
吉西他滨顺铂新辅助化疗用于肌肉浸润性膀胱癌的总剂量和剂量化疗对疗效及安全性的影响：每3周对比每4周一次给药方案
Karin Holmsten,Lise Høj Omland,Anne Birgitte Als et al.
Karin Holmsten et al.
Background: Neoadjuvant cisplatin-based chemotherapy is standard care prior to radical cystectomy in patients with muscle-invasive bladder cancer (MIBC). ...
Antibiotics and BCG [0.03%]
抗生素和BCG疫苗
Edward M Messing
Edward M Messing
Identification of a Novel Ferroptosis-Related Gene Signature for Prediction of Prognosis in Bladder Urothelial Carcinoma [0.03%]
一种新的铁死亡相关基因签名用于预测膀胱尿路上皮癌预后
Xiaokai Shi,Xiao Zhou,Lei Zhang et al.
Xiaokai Shi et al.
Background: sBladder urothelial carcinoma is the most prevalent type of bladder cancer, characterized by drug resistance, high recurrence rate, and unfavorable prognosis. Ferroptosis is a newly discovered type of non-apop...
Association between Patient-Reported Outcomes and Survival in Patients with Advanced Urothelial Carcinoma Treated with Atezolizumab [0.03%]
阿特珠单抗治疗晚期尿路上皮癌患者生存情况与患者报告结果之间的相关性分析
Eugene Tan,Ahmad Y Abuhelwa,Sarah Badaoui et al.
Eugene Tan et al.
Background: Atezolizumab is an immune checkpoint inhibitor (ICI) and a frontline treatment of patients with cisplatin-ineligible advanced urothelial carcinoma (UC). There is limited evidence on the prognostic value of pat...
Angela B Smith,Sean McCabe,Allison M Deal et al.
Angela B Smith et al.
Background: Bladder cancer treatments may variably impact health-related quality of life (QOL). Objective: To characterize the quality ...
Piyush K Agarwal,Cora N Sternberg
Piyush K Agarwal
Accuracy of Inchworm Sign on Diffusion-Weighted MRI in Differentiating Muscle-Invasive Bladder Cancer [0.03%]
DWI序列inchworm征在肌层浸润性膀胱癌中的诊断价值
Huseyin Ozgur Kazan,Meftun Culpan,Nesrin Gunduz et al.
Huseyin Ozgur Kazan et al.
Background: Inchworm sign is a finding on diffusion-weighted magnetic resonance imaging (DWI-MRI) and is used to better stratify T-staging in muscle invasive (MIBC) and non-muscle-invasive bladder cancer (NMIBC). An unint...